Publisher： John Wiley & Sons Inc
E-ISSN： 1744-9987|19|1|81-86
ISSN： 1744-9979
Source： THERAPEUTIC APHERESIS AND DIALYSIS, Vol.19, Iss.1, 2015-02, pp. : 81-86
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Oral Spironolactone Therapy in Male Patients with Rosacea
THE JOURNAL OF DERMATOLOGY, Vol. 19, Iss. 5, 1992-05 ,pp. :
Access to resources
Recommend
Systemic Levels of MMP2/TIMP2 and Cardiovascular Risk in CAPD Patients
Nephron Clin Pract, Vol. 115, Iss. 4, 2010-04 ,pp. :
Long-Term Low-Dose Spironolactone Therapy Is Safe in Oligoanuric Hemodialysis Patients
Cardiology, Vol. 114, Iss. 1, 2009-04 ,pp. :
Spironolactone and agranulocytosis
INTERNAL MEDICINE JOURNAL, Vol. 30, Iss. 4, 2000-08 ,pp. :